Skip to main content

Table 5 aORs from ordered logistic regression for participants eligible for DHP receiving a completed month of MDA

From: Risk factors for non-participation in ivermectin and dihydroartemisinin-piperaquine mass drug administration for malaria control in the MASSIV trial

Variables associated with receiving DHP amongst the eligible population (by completed Nr of monthly MDAs)

 

aOR

95% CI

p—value for specific variables

Likelihood ratio p—value

Household head receiving MDA

 None

1

  

 < 0.001

 Complete

1.64

1.33–2.04

 < 0.001

 Incomplete

1.07

0.85–1.34

0.564

Household size

  < 6

1

  

0.06

  > 6–12

0.85

0.45–1.62

0.628

  > 12–25

0.94

0.51–1.75

0.858

  > 25–50

0.77

0.41–1.43

0.41

  > 50

0.66

0.34–1.28

0.219

Ethnicity

 Fula

1

  

 < 0.001

 Mandinka

1.05

0.76–1.46

0.74

 Sarahule

0.78

0.44–1.39

0.399

 Wollof

6.21E + 07

(0 -.)

0.998

 Not specified

0.03

0.02–0.03

0.021

Age group

  < 5

2.01

1.59–2.54

 < 0.001

 < 0.001

  > 5–15

2.47

2.02–3.02

 < 0.001

  > 15–25

0.76

0.61–0.94

0.014

  > 25–50

1

  

  > 50

1.33

1.01–1.35

0.036

Sex

 Female

1

  

0.036

 Male

1.17

1.01–1.35

0.036